Dexmedetomidine increases the cocaine seizure threshold in rats

Abstract

Background: Central α adrenoceptors have been demonstrated to play an important role in the control of seizure activity; moreover, α 2 adrenoceptors have been linked to electroencephalogram changes associated with cocaine. The purpose of this study was to determine if dexmedetomidine, a highly selective α-adrenoceptor agonist, alters the threshold for cocaine-induced seizure activity in rats. Methods: Sprague-Dawley rats received a cocaine infusion (1.25 mg · kg -1 · min -1) followed 15 min later by the coinfusion of either dexmedetomidine (20-μg/kg intravenous bolus followed by an infusion of 1 μg · kg -1 · min -1, CD group, n = 8) or an equal volume of saline (CS group, n = 8). Dexmedetomidine or saline were coinfused with cocaine until the onset of cocaine-induced seizures. Dopamine concentrations in the nucleus accumbens were measured by microdialysis paired with chromatography. To determine if changes in extracellular dopamine were related to the seizures, dopamine (1 μM) was continuously delivered to the nucleus accumbens in a separate group (DACD group, n = 6) via retrograde microdialysis. These rats then received an intravenous cocaine infusion followed by dexmedetomidine in the same manner as the CD group. Results: Dexmedetomidine significantly increased the dose of cocaine necessary to produce seizures. Seizures occurred at 25.0 ± 7.7 and 49.3 ± 14.8 min in CS and CD, respectively (P < 0.001). The ratio of the percent increase in accumbal dopamine to the cocaine dose at the onset of seizure activity was significantly lower in CD, 39.9 ± 16.5, compared to CS, 82.2 ± 46.5 (P = 0.04). Intraaccumbal administration of dopamine prevented the effects of dexmedetomidine on the cocaine seizure threshold. Conclusions: These data suggest that dexmedetomidine increases the cocaine-induced seizure threshold possibly via a mechanism related to the attenuation of the extracellular dopaminergic neurotransmitter response to cocaine.